Recently, significant progress has been made in solving sophisticated problems among various domains by using reinforcement learning (RL), which allows machines or agents to learn from interactions with environments rather than explicit supervision. As the end of Moore's law seems to be imminent, emerging technologies that enable high performance neuromorphic hardware systems are attracting increasing attention. Namely, neuromorphic architectures that leverage memristors, the programmable and nonvolatile two-terminal devices, as synaptic weights in hardware neural networks, are candidates of choice to realize such highly energy-efficient and complex nervous systems. However, one of the challenges for memristive hardware with integrated learning capabilities is prohibitively large number of write cycles that might be required during learning process, and this situation is even exacerbated under RL situations. In this work we propose a memristive neuromorphic hardware implementation for the actor-critic algorithm in RL. By introducing a two-fold training procedure (i.e., ex-situ pre-training and in-situ re-training) and several training techniques, the number of weight updates can be significantly reduced and thus it will be suitable for efficient in-situ learning implementations. As a case study, we consider the task of balancing an inverted pendulum, a classical problem in both RL and control theory. We believe that this study shows the promise of using memristor-based hardware neural networks for handling complex tasks through in-situ reinforcement learning.
We trained and evaluated a localization-based deep CNN for breast cancer screening exam classification on over 200,000 exams (over 1,000,000 images). Our model achieves an AUC of 0.919 in predicting malignancy in patients undergoing breast cancer screening, reducing the error rate of the baseline (Wu et al., 2019a) by 23%. In addition, the models generates bounding boxes for benign and malignant findings, providing interpretable predictions.
Radiologists typically compare a patient's most recent breast cancer screening exam to their previous ones in making informed diagnoses. To reflect this practice, we propose new neural network models that compare pairs of screening mammograms from the same patient. We train and evaluate our proposed models on over 665,000 pairs of images (over 166,000 pairs of exams). Our best model achieves an AUC of 0.866 in predicting malignancy in patients who underwent breast cancer screening, reducing the error rate of the corresponding baseline.
In this paper, we apply machine learning to distributed private data owned by multiple data owners, entities with access to non-overlapping training datasets. We use noisy, differentially-private gradients to minimize the fitness cost of the machine learning model using stochastic gradient descent. We quantify the quality of the trained model, using the fitness cost, as a function of privacy budget and size of the distributed datasets to capture the trade-off between privacy and utility in machine learning. This way, we can predict the outcome of collaboration among privacy-aware data owners prior to executing potentially computationally-expensive machine learning algorithms. Particularly, we show that the difference between the fitness of the trained machine learning model using differentially-private gradient queries and the fitness of the trained machine model in the absence of any privacy concerns is inversely proportional to the size of the training datasets squared and the privacy budget squared. We successfully validate the performance prediction with the actual performance of the proposed privacy-aware learning algorithms, applied to: financial datasets for determining interest rates of loans using regression; and detecting credit card frauds using support vector machines.
Deep learning models designed for visual classification tasks on natural images have become prevalent in medical image analysis. However, medical images differ from typical natural images in many ways, such as significantly higher resolutions and smaller regions of interest. Moreover, both the global structure and local details play important roles in medical image analysis tasks. To address these unique properties of medical images, we propose a neural network that is able to classify breast cancer lesions utilizing information from both a global saliency map and multiple local patches. The proposed model outperforms the ResNet-based baseline and achieves radiologist-level performance in the interpretation of screening mammography. Although our model is trained only with image-level labels, it is able to generate pixel-level saliency maps that provide localization of possible malignant findings.
We present a deep convolutional neural network for breast cancer screening exam classification, trained and evaluated on over 200,000 exams (over 1,000,000 images). Our network achieves an AUC of 0.895 in predicting whether there is a cancer in the breast, when tested on the screening population. We attribute the high accuracy of our model to a two-stage training procedure, which allows us to use a very high-capacity patch-level network to learn from pixel-level labels alongside a network learning from macroscopic breast-level labels. To validate our model, we conducted a reader study with 14 readers, each reading 720 screening mammogram exams, and find our model to be as accurate as experienced radiologists when presented with the same data. Finally, we show that a hybrid model, averaging probability of malignancy predicted by a radiologist with a prediction of our neural network, is more accurate than either of the two separately. To better understand our results, we conduct a thorough analysis of our network's performance on different subpopulations of the screening population, model design, training procedure, errors, and properties of its internal representations.
In this work, we developed a network inference method from incomplete data ("PathInf") , as massive and non-uniformly distributed missing values is a common challenge in practical problems. PathInf is a two-stages inference model. In the first stage, it applies a data summarization model based on maximum likelihood to deal with the massive distributed missing values by transforming the observation-wise items in the data into state matrix. In the second stage, transition pattern (i.e. pathway) among variables is inferred as a graph inference problem solved by greedy algorithm with constraints. The proposed method was validated and compared with the state-of-art Bayesian network method on the simulation data, and shown consistently superior performance. By applying the PathInf on the lymph vascular metastasis data, we obtained the holistic pathways of the lymph node metastasis with novel discoveries on the jumping metastasis among nodes that are physically apart. The discovery indicates the possible presence of sentinel node groups in the lung lymph nodes which have been previously speculated yet never found. The pathway map can also improve the current dissection examination protocol for better individualized treatment planning, for higher diagnostic accuracy and reducing the patients trauma.
Advances in deep learning for natural images have prompted a surge of interest in applying similar techniques to medical images. The majority of the initial attempts focused on replacing the input of a deep convolutional neural network with a medical image, which does not take into consideration the fundamental differences between these two types of images. Specifically, fine details are necessary for detection in medical images, unlike in natural images where coarse structures matter most. This difference makes it inadequate to use the existing network architectures developed for natural images, because they work on heavily downscaled images to reduce the memory requirements. This hides details necessary to make accurate predictions. Additionally, a single exam in medical imaging often comes with a set of views which must be fused in order to reach a correct conclusion. In our work, we propose to use a multi-view deep convolutional neural network that handles a set of high-resolution medical images. We evaluate it on large-scale mammography-based breast cancer screening (BI-RADS prediction) using 886,000 images. We focus on investigating the impact of the training set size and image size on the prediction accuracy. Our results highlight that performance increases with the size of training set, and that the best performance can only be achieved using the original resolution. In the reader study, performed on a random subset of the test set, we confirmed the efficacy of our model, which achieved performance comparable to a committee of radiologists when presented with the same data.
Breast density classification is an essential part of breast cancer screening. Although a lot of prior work considered this problem as a task for learning algorithms, to our knowledge, all of them used small and not clinically realistic data both for training and evaluation of their models. In this work, we explore the limits of this task with a data set coming from over 200,000 breast cancer screening exams. We use this data to train and evaluate a strong convolutional neural network classifier. In a reader study, we find that our model can perform this task comparably to a human expert.